Asthma inhalers and colour coding: universal dots | British Journal of General Practice
Pharmaceuticals | Free Full-Text | Inhaled Corticosteroids
The Changing Role of Inhaled Corticosteroids in Asthma Management | NHLBI, NIH
Inhaled corticosteroids for adults with asthma - Best Practice Advocacy Centre New Zealand
Systematic Review of Intermittent Inhaled Corticosteroids and of Long-acting Muscarinic Antagonists for Asthma | Effective Health Care (EHC) Program
Inhaled Corticosteroids and LABAs — Removal of the FDA's Boxed Warning | NEJM
Reducing the use of inhaled corticosteroids in mild-moderate COPD
![PDF] Inhaled corticosteroids for adults with asthma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fe2f5eb4362989415139f5748c25cadd7cac0874/2-Figure1-1.png "PDF] Inhaled corticosteroids for adults with asthma | Semantic Scholar")
PDF] Inhaled corticosteroids for adults with asthma | Semantic Scholar
Asthma progression and mortality: the role of inhaled corticosteroids | European Respiratory Society
Long-term impact of inhaled corticosteroid use in asthma and chronic obstructive pulmonary disease (COPD): Review of mechanisms that underlie risks - Journal of Allergy and Clinical Immunology
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon - ScienceDirect
FDA clears generic asthma inhaler, inhaled corticosteroid
The 2019 GINA Guidelines for Asthma Treatment in Adults
Inhaled corticosteroids and pneumonia in chronic obstructive pulmonary disease - The Lancet Respiratory Medicine
Inhaled Corticosteroids (ICS) - AlphaNet
Pharmaceuticals | Free Full-Text | Inhaled Corticosteroids
The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study - Khalid Al Sulaiman, Ohoud Aljuhani, Kholoud Al Aamer, Omar Al Shaya, Abdulrahman Al Shaya, Alawi
Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease (COPD): Boon or Bane? | American Board of Family Medicine
Personalising add-on treatment with inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a benefit–harm modelling study - The Lancet Digital Health
Pharmaceuticals | Free Full-Text | Inhaled Corticosteroids
P35 Inhaled corticosteroids and pneumonia in COPD at primary care level | Thorax
Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective | European Respiratory Society
CHEST on Twitter: "Odds of tracheobronchomalacia with high-dose inhaled corticosteroids (ICS): * 3.5 times higher vs no steroids * 2.9 times higher vs low-dose ICS https://t.co/6CUfLrSk1o #journalCHEST #medtwitter https://t.co/7q3kGtX4nw" / Twitter
Inhaled Corticosteroids: Is There an Ideal Therapy?
